Multiple Sclerosis
This section highlights clinical protocols for a range of drugs.
Alemtuzumab
MS 100 Alemtuzumab Protocol, Version 3
MS 100 Alemtuzumab Patient Eligibility Form, Version 5
Natalizumab
MS101ab Natalizumab Protocol, Version 4.1
MS101ab Natalizumab Patient Eligibility Form, Version 5
Ocrelizumab
MS 102 Ocrelizumab (Ocrevus) Protocol for the treatment of relapsing Multiple Sclerosis (RMS)